BioMarin Pharma (BMRN) Tops Q3 EPS, Lowers FY Revenue Guidance
Go back to BioMarin Pharma (BMRN) Tops Q3 EPS, Lowers FY Revenue Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.75 +0.81 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.94 | 52 Week High | $108.96 | |||
| Open | $64.35 | 52 Week Low | $62.12 | |||
| Day High | $64.90 | P/E | N/A | |||
| Day Low | $63.58 | EPS | $-1.27 | |||
| Volume | 238,590 | |||||
